Results
Marksans Pharma Q1 Revenue Jumps 36% to ₹841 Crores
Marksans Pharma reported Q1 FY27 revenue of ₹840.8 crores, a 35.6% YoY growth, with record EBITDA of ₹213 crores and PAT of ₹159.4 crores.
The company completed two European acquisitions (QliniQ and A
